Lesaffre has acquired a majority stake in Biorigin, a business unit of Zilor, to improve the supply of yeast derivatives for savory ingredients. The global fermentation giant will become the controlling shareholder of Biorigin, with 70% of its total corporate capital. Zilor will retain its 30% share. 

The transaction includes Biorigin’s production unit in São Paulo, Brazil. The companies expect the cooperation to boost production processes, logistics and services in the natural-derived ingredients space of the human food and animal nutrition industries.

Brice-Audren Riché, CEO of Lesaffre says: “This acquisition of a majority stake in Biorigin will offer development opportunities to meet the growing needs of the human food and nutrition industries, as society currently demands savory ingredients from natural sources. We are stepping up to a new dimension thanks to this strategic move to reinforce Lesaffre and its Business Unit Biospringer by Lesaffre as global players in the field of yeast extracts for the savory ingredients market.”

“We are doing this with a key strategic partner, Zilor, who shares similar values to Lesaffre and a strong focus on CSR. Committed to delivering responsible taste through Biospringer and together with Biorigin, we are well-positioned to deliver enhanced yeast derivative and savory ingredient solutions to customers around the world.”